Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial

J.P. Ferreira; J.G.F. Cleland; N. Girerd; P. Pellicori; M.R. Hazebroek; J. Verdonschot; T.J. Collier; J. Petutschnigg; A.L. Clark; J.A. Staessen; S. Heymans; F. Zannad; P. Rossignol

doi:10.1007/s00392-022-02116-w

Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial

J.P. Ferreira^*
, J.G.F. Cleland
, N. Girerd
, P. Pellicori
, M.R. Hazebroek
, J. Verdonschot
, T.J. Collier
, J. Petutschnigg
, A.L. Clark
, J.A. Staessen
, S. Heymans
, F. Zannad
, P. Rossignol

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	330-332
Number of pages	3
Journal	Clinical research in cardiology
Volume	112
Issue number	2
Early online date	1 Oct 2022
DOIs	https://doi.org/10.1007/s00392-022-02116-w
Publication status	Published - Feb 2023

Access to Document

10.1007/s00392-022-02116-w

Cite this

Ferreira, J. P., Cleland, J. G. F., Girerd, N., Pellicori, P., Hazebroek, M. R., Verdonschot, J., Collier, T. J., Petutschnigg, J., Clark, A. L., Staessen, J. A., Heymans, S., Zannad, F., & Rossignol, P. (2023). Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial. Clinical research in cardiology, 112(2), 330-332. https://doi.org/10.1007/s00392-022-02116-w

@article{e7de20807d2e4a768ce8ffb162538e54,

title = "Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial",

author = "J.P. Ferreira and J.G.F. Cleland and N. Girerd and P. Pellicori and M.R. Hazebroek and J. Verdonschot and T.J. Collier and J. Petutschnigg and A.L. Clark and J.A. Staessen and S. Heymans and F. Zannad and P. Rossignol",

note = "Funding Information: Thie research was supported by FP7 Science in Society (Grant HEALTH-F7-305507 HOMAGE). ",

year = "2023",

month = feb,

doi = "10.1007/s00392-022-02116-w",

language = "English",

volume = "112",

pages = "330--332",

journal = "Clinical research in cardiology",

issn = "1861-0684",

publisher = "Springer",

number = "2",

}

Ferreira, JP, Cleland, JGF, Girerd, N, Pellicori, P, Hazebroek, MR, Verdonschot, J, Collier, TJ, Petutschnigg, J, Clark, AL, Staessen, JA, Heymans, S, Zannad, F & Rossignol, P 2023, 'Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial', Clinical research in cardiology, vol. 112, no. 2, pp. 330-332. https://doi.org/10.1007/s00392-022-02116-w

TY - JOUR

T1 - Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial

AU - Ferreira, J.P.

AU - Cleland, J.G.F.

AU - Girerd, N.

AU - Pellicori, P.

AU - Hazebroek, M.R.

AU - Verdonschot, J.

AU - Collier, T.J.

AU - Petutschnigg, J.

AU - Clark, A.L.

AU - Staessen, J.A.

AU - Heymans, S.

AU - Zannad, F.

AU - Rossignol, P.

N1 - Funding Information: Thie research was supported by FP7 Science in Society (Grant HEALTH-F7-305507 HOMAGE).

PY - 2023/2

Y1 - 2023/2

U2 - 10.1007/s00392-022-02116-w

DO - 10.1007/s00392-022-02116-w

M3 - Comment/Letter to the editor

C2 - 36279002

SN - 1861-0684

VL - 112

SP - 330

EP - 332

JO - Clinical research in cardiology

JF - Clinical research in cardiology

IS - 2

ER -